Clinical Trial

Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes

Recruiting
View on ClinicalTrials.gov →
Summary
Why Is This Research Study Being Conducted? * The study wants to find out why people with a type of blood cancer called myelodysplastic syndromes (MDS) are more likely to have heart problems like heart disease and stroke. * Researchers also want to see if certain proteins related to inflammation in the body can help predict these heart issues in MDS patients. * By understanding this better, researchers hope to find new ways to detect and manage heart disease risks in people with MDS
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-14; most recent amendment 2026-02-02.
Trial Details
NCT Number NCT06692894
Lead Sponsor University of Vermont
Conditions Myelodysplastic Syndromes, Adult
Enrollment 30 participants
Start Date 2024-11-05
Primary Completion 2027-11 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-02-03